An exceptional panel of international experts met in parallel to the 3rd IRF Symposium to discuss Intellectual Property as a key to business growth and value creation. They presented clear indications of best practice in this area, exploring both policy issues and technological decision-making breakthroughs.

Participants were on the one hand senior operating executives from research-driven companies like the Austrian voestalpine and the US pharmaceutical group Pfizer, on the other hand innovation management and intellectual property experts. The lively discussions delivered concrete cost-effective IP optimizations on the best way of managing intellectual property and the performance of an R&D department.